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Befriending is an emotional supportive relationship in which one-to-one companionship is 
provided on a regular basis by a volunteer. It is commonly and increasingly offered by the 
voluntary sector for individuals with distressing physical and mental conditions. However, 
the effectiveness of this intervention on health outcomes is largely unknown. We aim to 




A systematic search of electronic databases was conducted to identify randomized controlled 
trials and quasi-experimental trials of befriending for a range of physical and mental health 
indications including depression, anxiety, mental illness, cancer, physical illness, and 
dementia. Main outcomes included patient-relevant and disease-specific outcomes, such as 
depression, loneliness, quality of life, self-esteem, social support, and well-being. 
Results 
A total of 14 trials (2411 participants) were included; seven were judged at low risk of bias. 
Most trials showed improvement in symptoms associated with befriending but these 
associations did not reach statistical significance in all trials. Befriending was significantly 
associated with better patient reported outcomes across primary measures (standardised mean 
difference [SMD] 0.18 [95% CI, -0.002–0.36, I2 = 26%, 7 trials]). However, there was no 
significant benefit on single outcomes, including depression, quality of life, loneliness 




There was moderate quality evidence to support the use of befriending for the treatment of 
individuals with different physical and mental health conditions. This evidence refers to an 
overall improvement benefit in patient reported primary outcomes, albeit with a rather small 
effect size. The current evidence base does not allow for firm conclusions on more specific 
outcomes. Future trials should hypothesize a model for the precise effects of befriending and 
use specified inclusion and outcome criteria.  
 
Article Summary: Strengths and Limitations of this Study  
• This is the first comprehensive systematic review that identifies the benefits of 
befriending in multiple outcomes.  
• The selection of patient reported primary outcomes in each study for analysis avoided 
bias of studies reporting significant secondary outcomes. 
• There may be missing data on participation rates and this influenced our 





Individuals with physical or mental health impairments can often become isolated and 
have limited support networks. One possible avenue for building and sustaining social 
relationships in the community for these individuals is through befriending. This term was 
initially introduced in the 16th century and was known as a process of “act[ing] as a friend to, 
to help, favour, to assist and promote.”[1] This humanistic purpose later evolved into a 
formal befriending program for suicidal crisis in 1962 which redefined befriending as the 
provision of “companionship and support of a friend to [a client] especially in a lay 
capacity”[2]. The practice of befriending has been largely adopted by the voluntary sector, 
with over 3500 schemes existing in the UK alone [3], where volunteers support a range of 
populations including individuals with mental illness or dementia, suffering from 
bereavement, requiring refuge and suicide prevention. Despite this, there has been criticisms 
about the precise definition of befriending, its mechanisms and how and for whom it is used 
most effectively [4, 5]. Currently applied in social and health care settings, befriending is 
often conceptualised and practiced as a marked alternative to staff-delivered, professional 
care (i.e., placebo in clinical settings) where volunteers provide compassionate social support 
and companion resources to meet the care needs of the befriender. For the purposes of this 
review, we identify befriending as a supportive and uni-directional relationship that aims to 
alleviate loneliness and provide social support through the provision of one-to-one regular 
companionship by volunteers.  
There is relatively little research examining befriending interventions, but what has 
been done provides some promise for their effectiveness. Some evidence suggests that 
befriending can provide individuals with a new direction in life, re-establish engagement with 
social activities and encourage self-esteem for mental illness (e.g. schizophrenia [6]) and 
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health conditions (e.g., heart failure [7]) but these studies are largely conducted using 
qualitative methods and do not evaluate specific outcomes in well-designed comparative 
studies. 
A recent meta-analysis on the impact of befriending on depressive symptoms and 
emotional distress found a modest effect in varied patient groups including individuals with 
prostate cancer or dementia [8]. However, this review was limited in that it focused on 
depressive symptoms and emotional distress only, and included studies examining peer 
support and paid professional staff. Since relationships such as mentoring, peer support, and 
befriending have individual distinctive features that provide different support functions and 
have different aims with regard to promoting social inclusion (e.g., peer support incorporates 
themes of mutual support and self-help) [4] , a more comprehensive review updating and 
assessing the effectiveness of befriending will be beneficial. It will not only provide 
additional insight into other clinical and social outcomes but may also reveal additional 
insight into other populations and aid future implementation of befriending services. 
Thus, the aim of this systematic review was to evaluate the evidence for the 
effectiveness of befriending across a broad range of health conditions and clinical and social 
outcomes.  
Methods 
This review followed guidance published by the Centre for Reviews and 
Dissemination and the Cochrane Collaboration [9, 10].  
Study Eligibility Criteria 
Randomized controlled trials (RCTs) that compared befriending with usual care or no 
treatment in any physical health or mental health area were eligible. We included studies for 
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individuals of all ages, residing in the community and allocated to a befriending intervention, 
irrespective of ethnicity, gender, nationality or health status. Befriending was defined as an 
intervention that introduces the patient to one or more individuals whose main aim is to 
provide the patient with additional social support through the development of an affirming, 
emotion-focused relationship over time. The relationship should be established by and 
monitored via an agency. The social support should be primarily non-directive and emotional 
in nature, with the core focus of building a “friendship”. Studies were excluded where 
informational, instructional or appraisal support formed a key component of the intervention. 
Additionally, the befriending sessions were delivered by volunteers and offered as a 
free service. When befriending is used as a comparison to a therapy-based study (e.g., control 
befriending), this was excluded as this type of befriending is typically administered by a paid 
professional worker with a focus on developing a directive, non-emotional focused 
relationship. Studies where the volunteer was a member of the patient’s existing social or 
care provider network (e.g., family member, caseworker, general practitioner) or was an 
individual who had experienced the same conditions as the patient (e.g., peer, mentor) were 
also excluded. 
To be comprehensive, non-randomized studies such as case series that evaluated 
befriending for a particular outcome that was not identified elsewhere (e.g., cancer) were 
included for review. 
Identification and Selection of Studies 
Nine databases and grey literature sources were searched from inception to February 
2016 without language restriction. A systematic search of the literature was conducted using 
online databases, relevant psychiatric journals and grey literature which included: 
MEDLINE; EMBASE; PsycINFO; Cochrane Central Register of Controlled Trials; 
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CINAHL; Web of Knowledge; BI, Web of Science and Google Scholar. Electronic searches 
were supplemented with manual scanning of the reference lists of retrieved articles and 
known reviews of social support interventions. The flow of studies is illustrated in Figure 1.  
Specific search strategies were developed for each database, using a combination of 
text terms and subject headings where applicable. Please see Supplementary File 1 for more 
detail. Overall, this involved four lists of search terms: 
a) ‘volunteer descriptors’ including befriend*, companion, friend, lay helper, compeer, 
peer, buddy, unpaid carer, informal caregiver, voluntary caregiver, naturalistic 
support, supported socialisation, psychosocial support, supported friendship, peer 
assistance, intentional friendship, consumer run services, consumers as providers, 
consumers-as-providers, community support, community services, paraprofessional*, 
nonprofessional volunteer*, nonprofessional worker*, citizen participation, civic 
participation, program, voluntary, helping others, supported socialization. 
b) ‘mental health descriptors’  including mental health, mental illness, mental problem, 
mental disorder, mental health scheme, mental health charity, mental health project, 
mental health program*, mental health organisation, mental health service, mental 
health care, psychiatry, psychiatric scheme, psychiatric charity, psychiatric project, 
psychiatric program*, psychiatric organisation, psychiatric service, psychiatric care, 
psychosis, schizophrenia, severe mental illness, depression, anxiety, disorder, eating 
disorder, phobia. 
c) ‘health descriptors’ including end of life care, palliative care, palliative, dementia, 
dementia care*, physical disabilities, HIV, AIDS, cancer, diabetes, heart failure, 




d) ‘outcome descriptors’ including motivation*, motive*, reason*, opinion*, attitude*, 
experience*, reward*, benefit*, success*, drawback*, negativ*, positive*, ‘failure*, 
challenge*, difficult*, altruistic, psychological health, functioning, happiness, 
satisfaction, self-esteem, empowerment, well-being, outcome*. 
One reviewer (JS) screened titles and abstracts to determine potential inclusion, with a 10% 
random sample of records independently screened by a second reviewer (MC). Articles were 
double blind coded. Inclusion was subsequently confirmed by a team of three reviewers (JS, 
MC, SP) who independently checked the full text of all retrieved articles. Uncertainties and 
disagreements were resolved through team discussion and/or contact with study authors (see 
Supplementary File 2 for the list of excluded articles).  
Data Collection and Study Appraisal 
A broad and inclusive search strategy was adopted for a systematic appraisal, 
assessment and extraction of information from reports. We extracted data about baseline 
characteristics and outcomes including patient relevant and disease specific outcomes. For 
categorical data, we extracted details about each category assessed and the number of 
individuals with an outcome in each category. Continuous data such as the Hamilton Anxiety 
and Depression Scale were extracted as means and SDs at baseline, follow-up, and the 
change from baseline and used to calculate mean differences with 95% CIs. Results (mean 
difference, 95% CIs, and P values) from the between group statistical analyses, reported by 
the study, were also extracted. All relevant sources were used for data extraction including 
full-text journal articles, abstracts, and clinical trial registry entries.  
The extraction of findings, data outcomes and concepts from key papers was 
completed independently by two authors (JS, MC). Data extraction included author details, 
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year of publication and publication type, participant demographic details, sample size, 
interventions investigated, outcomes measured, results of intervention, and key findings.  
To assess the methodological quality of the studies included, we used two procedures 
designed to preserve group comparability in the Cochrane Collaboration Risk of Bias tool 
[11]. Briefly, this assesses allocation concealment to protect against selection bias, and loss to 
follow-up. Study quality was rated ‘high’ if allocation was adequately concealed and at least 
80% of participants underwent follow-up, ‘medium’ if one of these criteria was met, and 
‘low’ if neither was met. Two authors (JS and MC) assessed the risk of bias, and 
disagreements were resolved by discussion. 
Data Synthesis 
Studies were grouped by conditions and outcomes. Outcome variables that were 
assessed in at least four eligible RCTs comparing befriending to another intervention were 
qualified for inclusion in a separate meta-analysis. This resulted in meta-analyses for seven 
outcome types. Reported measures included a mix of dichotomous and continuous outcomes. 
We translated continuous measures to a standardised effect size (i.e., mean of intervention 
group minus mean of control group, divided by the pooled standard deviation). Per standard 
protocol, outcomes reported as dichotomous variables were translated to standardized effect 
sizes using the logit transformation.  
The Comprehensive Meta-Analysis software package, version 2.2.021, was used for 
all analyses and calculations. Heterogeneity was investigated using forest plots and measured 
using the I2 statistic, which estimates the percentage of total variation across studies that can 
be attributed to heterogeneity rather than chance. Where data were considered too 
heterogeneous to pool or not reported in a format suitable for pooling (e.g., data reported as 
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medians), we used a narrative synthesis for evaluation. As a result of the varied nature of the 
interventions include, a random effects model was adopted and analysed.  
Patient-reported outcomes are increasingly important in the evaluation of 
psychosocial treatment and complex interventions in particular mental health care, as such 
outcomes capture patients’ views, feelings and judgements. Recent evidence suggests a large 
number of variance of patient ratings across symptoms, quality of life and needs can be 
explained by one global factor [12]. Additionally, the assessment of primary outcomes only 
may provide valuable insight into the effectiveness of interventions as it avoids reporting bias 
(especially for studies that provide only significant secondary outcomes), and ensures that the 
analysis considers what the study and intervention model regarded as important [13]. We 
therefore separately compiled patient reported primary outcomes for analysis. 
Results  
Selection of studies 
Searches generated 20,706 records. After the removal of duplicates and the 
application of inclusion and exclusion criteria on titles and abstracts, 129 full-text papers 
were evaluated. A final 14 studies (2411 participants) reported data on befriending 
interventions for individuals and were subsequently included in this review (Figure 1).  
Characteristics of populations and outcome measures 
The characteristics of the 14 included studies are summarized in Table 1. The 
included studies were published between 1991 and 2015. The total number of individuals 
assessed was 2411, which ranged from one study of four participants to one study of more 
than 500 participants. Eleven studies were randomized controlled trials [14-24] and three 
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were quasi-experimental studies [25-27]. Eight studies were conducted in the UK, two in 
Canada, two in USA, one in Finland and one in Australia. Seven studies were rated high 
quality, three studies medium, and four low (Supplementary File 3). 
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Table 1. Summary of studies, demographics, measures and outcomes 
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measure), use of 
health services 
(frequency) 
ADL, Activities of Daily Living Scale; BDI, Beck Depression Index; BPRS, Brief Psychiatric Rating Scale; CBS-EOLC, Caregiver’s Burden Scale in End-of-Life 
Care; CES-D, Center for Epidemiological Studies Depression Scale; CSI, Colorado Symptom Index; DJG, De Jong Gierveld Loneliness Scale; ECOG, 
Performance Status Scale; EQ-5D, EuroQol-5D; GAF-M, Global Assessment of Functioning-Modified; GHQ, Global Health Questionnaire; GSE, General 
Perceived Self Efficacy; HADS, Hamilton for Anxiety and Depression Scale; HHS, Herth Hope Scale; HPQ, Health Perceptions Questionnaire; HSC, Hopkins 
Symptom Checklist; ISEL, Interpersonal Support Evaluation List; LQoL, Lehman Brief Quality of Life Interview; LRI, Life Regard Index; MDES, Making Decisions 
Empowerment Scale; mMOS-SS, modified Medical Outcomes Study Social Support Survey; MORS, Mothers Object Relationship Scale; MSPSS, Multidimensional 
Scale of Perceived Social Support; MSSI, Maternal Social Support Index; NES, Network Embeddedness Scale; ONS, Office for National Statistics Well-being Scale; 
PANT, Practitioner Assessment of Network Type; PGC, Philadelphia Geriatric Centre Morale Scale; PHQ-9, Patient Health Questionnaire; PNAS, Positive and 
Negative Affect Schedule; PRQ Personal Resource Questionnaire; PSE-10, Present State Examination; PSS, Perceived Social Support Scale; RAS, Recovery 
Assessment Scale; RSE, Rosenberg Self-Esteem Scale; SCID, Structured Clinical Interview for DSM-IV; SCNS, Supportive Care Needs Survey; SELSA-S, Social 
and Emotional Loneliness Scale for Adults; SF-36, Short Form Health Instrument; SFS, Social Functioning Scale; SPPB, Short Physical Performance Battery; 
WBS, Wellbeing Scale; WHO QOL-BREF, World Health Organisation Quality of Life Short Version Scale. 
*Scale developed by Paloutzian and Ellison (1982)[28]. 
#Primary outcome reported as a Patient Reported Outcome Measure.
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With respect to diagnostic categories, befriending was implemented in a range of 
populations including five studies for elderly participants who required physical and 
emotional support [17, 18, 20, 24], were depressed [19], or had mobility limitations [21]. 
Three studies focused on individuals with severe mental illness as diagnosed by ICD-10 [15, 
22, 27] and two studies focused specifically on women with anxiety and depression [16, 25]. 
The other four studies examined separate categories, including carers in dementia [14], 
individuals with learning disabilities [26], and individuals with colorectal cancer [23].  
In terms of outcome measures, depression was evaluated in nine studies [14-16, 19, 
20, 22, 23, 25], loneliness was assessed in five studies [14, 17, 20, 22, 24], quality of life was 
evaluated in five studies [14, 18, 20, 21, 24], self-esteem was measured in three studies [15, 
20, 22], social support in six studies [14, 17, 18, 24, 25, 27], and well-being in four studies 
[15, 17, 20, 21, 27]. A range of other outcomes were also measured in each individual study 
and these included social networks [24, 26], clinical symptoms [14, 15, 27], social 
functioning [15, 22], functional impairment [18], physical health [17, 19, 21], functional 
ability [18], health perception [18], care needs [23] and carer burden [24]. 
All studies identified a primary outcome which included measures across depression 
[14-16, 19, 23, 25], social support [17, 18, 27], social network [26], mental well-being [20], 
quality of life [21, 24] and social functioning [22] (Table 2). There were seven patient 
reported outcomes and seven clinician reported outcomes. Specific to patient only reported 
outcomes, there was one outcome for depression [15], mental well-being [20], social 
functioning [22], respectively, and two outcomes for social support [17, 18] and quality of 

























Study Primary Outcome Type of rating 
Charlesworth (2008) Depression Clinician 
Coe (2013) Depression Clinician 
Davidson (2004) Depression Patient 
Harris (1999) Depression Clinician 
Heller (1991) Social Support Patient 
Hughes (1999) Social Network Patient 
MacIntyre (2002) Social Support Patient 
McCorkle (2008) Social Support Patient/Clinician 
McNeil (1991) Depression Patient 
Mountain (2014) Mental well-being Patient 
Rantanen (2015) Quality of life Patient 
Sheridan (2015) Social functioning Patient 
Walshe (2016) Quality of life Patient 




Characteristics of befriending intervention  
The nature of the befriending intervention was characterized by who delivered the 
befriending, who the befrienders were, whether training was offered, how the scheme was 
delivered, whether the pair went through a matching process and the length of adherence 




Table 3. Summary of befriending interventions 
 







1 day for 
befriending 
facilitator and 12 





health and safety 
and 
confidentiality 
Face to face in 
patient’s home 
Weekly 1 hour 
sessions over 6 
months 
Yes, on locality 
and knowledge 









achieved due to 
carer time 
commitments 












Face to face in 
patient’s home / 
attendance at a 
support group 
Weekly contact 
over 12 months 
Not specified. 15-24% did not 
attend the 
service, or did 
not continue 










well as ongoing 
monthly support 
meetings 
Face to face in 
patient’s home 
and in the 
community 
Weekly contact 
for 2-4 hours 
over 9 months 
Yes, based on 
shared interests, 
age and gender 
36% did not 










Face to face in 
patient’s home 
One contact per 
week for 1 h over 
12 months 




23% did not 
meet befriender 
at all and 19% 
had 1 meeting. 
40% received 





Heller (1991) Academic Trained female 
interviewers 
Yes, details not 
specified 
Telephone only Twice a week for 
5 weeks, then 
once a week for 5 
weeks 
Not specified Not clear 









Face to face at 
group house 
Once a week 
over 4 months 
Not specified 75% did not 
continue 









safety in relation 
to mobility aids 
and client’s 
diagnosis 
Face to face in 
patient’s home 
Once a week for 
3-4 hours over 6 
weeks 











Yes Face to face at 
patient’s home  
4 hours monthly 
over 12 months 
Yes, on client’s 














Not clear Face to face in 
patient’s home 
(or nearby) 
Two visits per 
week of 20-40 


















one calls. Up to 5 
volunteers 
simultaneously 
received four 1 
hour sessions in 
group facilitation 
skills. They were 





One call of 10-20 
minutes a week 
over 6 weeks, 
followed by 1 
hour 
teleconferences 
of up to six 
participants once 
a week over 12 
weeks. 
Not specified Not specified 
Rantanen (2015) Academic Volunteer 
befrienders 







skills and duties; 
monthly support 
sessions 
Face to face at 
various out-of-
home activities 
Once a week 
over 3 months 
Yes – based on 
discretion e.g., 
locality 
80% of patients 
met at least 7 





Sheridan (2015) Academic Volunteer 
befrienders 
(stipend received 
for the session) 
Yes – 1-day 
training program 
Face to face at 
patient’s home 
and in the 
community 
Once a week for 
2 hours over 9 
months. 
Yes – based on 
demographic, 
social and leisure 
profile 
Not specified 













Typically, face to 
face at patient’s 




Once a week for 
1-3 hours for 4 
weeks 
Yes – details not 
specified 
Not specified 
















Telephone only Once a week 
over 9 months 
Not specified Not specified 
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The befriending intervention was typically facilitated by an external agency such as the local 
voluntary organisation that already supports such a program and was evaluated and supported 
by an academic institution.  
Although the befriender had volunteered for the role in all studies, there were two 
studies that provided a stipend to the befriending pair during their sessions for their activities 
[15, 22]. Volunteers ranged in age, gender and occupation. Most volunteers were provided 
training except for two studies who we were unable to verify training details. Training ranged 
from one session of one hour to a six-day training course. Volunteers were often provided 
further support in monthly group meetings.  
Befriending was given either face-to-face at the patient’s home, which was focused on 
the development of a supportive, one-to-one social relationship, or over the phone which was 
focused on providing practical, informational, emotional and supportive care. In face-to-face 
interactions, befriending was always delivered one-on-one, but over the telephone, 
befriending was delivered initially in a one-to-one arrangement followed by group 
teleconferencing opportunities.  
Befriending involved a variable number of contacts and duration, where sessions were 
typically arranged for weekly visits/calls for a minimum of 6 weeks to a maximum of 12 
months. However, there was one study that delivered a befriending scheme for twice weekly 
visits across 6 weeks. Participants were engaged for a minimum of 20 minutes to 180 minutes 
during their session. Median figures suggest weekly contacts of 1 hour’s duration delivered 
for approximately 3 months. 
Seven studies included details on matching which discussed an attempt of matching 
the befriending pair based on similarity of background, interests, locality, age and gender. 
Adherence to the program was described in 10 studies and ranged from 32% to 100% of the 
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scheme’s duration. However, as befriending schemes differed in length it is difficult to 
estimate how long a befriending pair did regularly convene. 
Effectiveness of befriending 
Befriending was evaluated across multiple outcomes including depression, loneliness, 
quality of life, self-esteem, social support, well-being and patient reported primary outcomes 
(Figure 2, Supplementary File 4).   
Eight comparisons of befriending and usual care or no treatment included a measure 
of depression as their primary outcome and provided suitable data for meta-analysis. 
Befriending had no effect on depressive scores (p=0.12), with a standardised mean difference 
(SMD) of -0.05 (95% CI 0.11 to -0.21, I2 = 41%).  
Five comparisons of befriending to usual care or no treatment assessed quality of life 
as an outcome. Befriending demonstrated a borderline significant effect on this measure 
(p=0.08); there was a SMD of 0.24 (95% CI 0.52 to -0.03, I2 = 57%).  
Five comparisons included a measure of loneliness and demonstrated a SMD of -0.03 
(95% CI 0.12 to -0.18, I2 = 0%). Five comparisons examined social support measures, with a 
SMD of 0.08 (95% CI 0.28 to -0.11, I2 = 59%; whilst five comparisons assessing well-being 
reported a SMD of 0.15 (95% CI -0.08 to 0.38, I2 = 49%). These outcomes did not reach 
statistical significance. 
Seven comparisons of patient reported primary outcomes provided a significant effect 





The review identified 14 trials that tested befriending for patients with different 
diagnoses such as cancer, depression, and severe mental illness. The befriending schemes 
shared several key characteristics. They match individual patients with volunteers, who are 
given brief training, and although there are some variations between befriending programs (in 
terms of their frequency, length of contact and method of delivery), a core component is the 
fostering of a social relationship between a volunteer and patient who engage in social and 
recreational activities. In our evaluation of befriending programs, we found evidence only for 
the effectiveness of befriending in combined primary outcomes reported by patients, although 
the effect was small. 
Strengths and limitations 
This review used a systematic approach to collate the published literature to date on 
befriending interventions. The review used rigorous methodology with a wide search 
strategy. Another strength is our selection of patient reported primary outcomes in each study 
for analysis to avoid bias of studies reporting significant secondary outcomes. We further 
stratified analyses based on outcome type to identify and investigate differences between 
associations.  
One limitation relates to data on participation rates. Not all of the studies reported 
participation rates, and of those that did, it was not always possible to derive an average of 
the rate of participation. There was also a lack of data on participant engagement with 
befriending across time. It might be that participants initially engage very well with 
befriending schemes but after time drop out, when in fact greater experience with the 
intervention is needed for participants to find it helpful. Such findings will have an impact on 
determining the optimal length of time for befriending which, given the paucity of relevant 
data in the included studies, could not be established in this review.  
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An additional limitation is the combination of different patient reported outcomes in 
one meta-analysis. The importance of incorporating patients’ views about outcome 
measurement and reporting within RCTs has been highlighted by recent guidance [29] and 
although different constructs may appear to be conceptually distinct, there is significant 
overlap between patient reported outcomes such as depression, well-being, and quality of life. 
For instance, greater well-being is associated with enhanced quality of life [30] and there is 
evidence that a general subjective appraisal factor is able to summarise all subjective 
evaluation outcomes [12].  
Comparison with literature 
This review is unable to entirely support previous reports that patients engage well 
with a befriending program and that there are some benefits. In contrast to an earlier review 
and meta-analysis [8] we were unable to replicate the significant effect of befriending on 
depressive symptoms. Whilst the earlier review conducted their analyses in short- and long-
term befriending, we did not identify a significant result for either case. However, the studies 
reviewed differ widely, with only four studies [14, 16, 17, 19] overlapping between the two 
reviews due to our inclusion criteria. It is thus difficult to draw direct comparisons with the 
previous review given the nature of our befriending definition. 
Implications for research and practice 
As the quality of trials identified in the review remains inconsistent, it is unclear 
whether befriending does have an impact on outcomes. Although an overall significant effect 
was found for patient reported outcome measures, such a small effect size does not appeal to 
an adoption of this intervention. As our current evidence does not allow for conclusions about 
more specific effects, future research should specify a model for the hypothesized effect of 
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befriending, select patients accordingly and use an appropriate outcome measure. The current 
system of measuring different outcomes when participants did not necessarily have a 
problematic baseline of the given measure to start with will make finding effects that are 
statistically and practically significant difficult. It is thus questionable whether the established 
criteria capture the importance of befriending at all, or rather it is being used for its 
humanistic, integrative and cohesive function. 
Regardless, qualitative reviews suggest that befriending can be a useful complement 
to current clinical practices given its user acceptability and potential to influence mental 
health outcomes and personal relationships [4, 5, 31, 32]. However, a number of practical 
factors should to be considered when designing future befriending practices and build this 
into an appropriate befriending model. This includes (1) defining the targeted population; (2) 
balancing the frequency, length and modality of befriending; (3) identifying how befriending 
influences clinical and social outcomes; and (4) the nature of the infrastructure required to 
delivery community befriending services. For instance, a sample befriending model for an 
elderly individual with depression would include participants with a moderate level of 
depression prior to commencing the program. Once engaged, this would involve regular face-
to-face meetings with the volunteer to provide support as well as helping out with groceries 
and everyday living. The focus of this pairing would be to build a ‘genuine friendship’, and to 
ensure success, the volunteer and patient will be matched well, and the pair/organisation will 
develop realistic outcomes together in a supportive and sustainable context. To establish an 
empathic relationship, training for the participants’ expectations, attitudes and behaviour, 
targeting mutuality and reciprocity between the pair will be provided. Other befriending 
models can further consider whether, for some mental and/or physical conditions, befriending 
is only useful in the early phase of illness, whether multiple befriending pairs (i.e., group 
befriending) or a longer befriending commitment (e.g., greater than one year) would provide 
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more social support, and whether a focus on specific activities (e.g., recreational vs physical) 
with different media (e.g., online) would be more suitable for particular patient groups.  
Conclusions 
The current review has identified patient reported gains as a result of befriending. However, 
due to the large heterogeneity in the extracted studies, it is unclear how precisely befriending 
programs can facilitate social integration and recovery for particular individuals. Future 
research into befriending should examine befriending models designed for specific patient 
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Figure 1.PRISMA Diagram. 
 
Figure 2. Effectiveness of befriending. Standardized mean difference (SMD) indicate no 
improvement in depression, loneliness, quality of life, self-esteem, social support, and well-
being scores with befriending. The square data markers indicates SMD from primary studies, 
with sizes reflecting the statistical weight of the study using random-effects meta-analysis. 
The horizonal lines indicate 95% CIs. The diamond data marker represens the overall SMD 
and 95% CI for each outcome. The vertical dashed line shows the summary effect estimate, 
the dotted shows the line of no effect (SMD = 0). 
 
Table 1. Summary of studies, demographics, measures and outcomes. 
 
Table 2. Study selection and details for patient reported primary outcomes. 
 









Supplementary File 1. Search Strategy 
Supplementary File 2. Excluded Articles and Reasons. 
Supplementary File 3. Study Quality.  
Supplementary File 4. Funnel Plot of standard error by standard difference in means. 
The funnel plot is centred at the value under the null hypothesis of no effect (i.e., 0). The 
white region in the middle corresponds to p-values greater than 0.10, the grey-shaded region 
for p-values between 0.10 and 0.05, the dark grey-shaded region for p-values between 0.05 
and 0.01, and the region outside of the funnel for p-values below 0.01. Egger’s regression test 
intercept 0.242 (t = -1.93, d.f. = 6, p = 0.112). There is no evidence of publication bias. 
 
